During the past decade, Charles M. Barrett Cancer Center at University Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 43 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Charles M. Barrett Cancer Center at University Hospital" #1 sponsor was "SWOG Cancer Research Network" with 40 trials, followed by "Radiation Therapy Oncology Group" with 24 trials sponsored, "Gynecologic Oncology Group" with 16 trials sponsored, "Alliance for Clinical Trials in Oncology" with 13 trials sponsored and "NSABP Foundation Inc" with 13 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charles M. Barrett Cancer Center at University Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 111 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Cancer and Leukemia Group B" with 13 trials as a collaborator, "Eastern Cooperative Oncology Group" with 10 trials as a collaborator and "North Central Cancer Treatment Group" with 8 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Charles M. Barrett Cancer Center at University Hospital" are "Lung Cancer" (25 trials), "Breast Cancer" (19 trials), "Prostate Cancer" (11 trials), "Lymphoma" (9 trials) and "Brain and Central Nervous System Tumors" (6 trials). Many other conditions were trialed in "Charles M. Barrett Cancer Center at University Hospital" in a lesser frequency.

Most popular intervention types in "Charles M. Barrett Cancer Center at University Hospital" are "Drug" (86 trials), "Radiation" (42 trials), "Procedure" (31 trials), "Biological" (23 trials) and "Other" (20 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (21 trials), "docetaxel" (13 trials), "cisplatin" (12 trials), "paclitaxel" (10 trials) and "conventional surgery" (9 trials). Other intervention names were less common.

The vast majority of trials in "Charles M. Barrett Cancer Center at University Hospital" are 73 trials for "All" genders, 35 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Charles M. Barrett Cancer Center at University Hospital". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 93 completed trials in Charles M. Barrett Cancer Center at University Hospital, undefined suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Charles M. Barrett Cancer Center at University Hospital, 5 "Phase 1" clinical trials were conducted, 51 "Phase 2" clinical trials and 53 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".